Christopher Parrish

Assistant Professor, Division of Allergy & Immunology

University of Texas Southwestern Medical Center

United States

Research Interests

Explore related searches

Professors in United States Professors in Immunology Immunology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Christopher Parrish is an Assistant Professor in the Division of Allergy & Immunology at the University of Texas Southwestern Medical Center. His research primarily focuses on food allergies, including the efficacy and safety of immunotherapies and addressing health disparities in food allergy care. Recent publications include studies on omalizumab treatment and epicutaneous immunotherapy in children, as well as the review of food allergy management practices.

Articles (10)

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2020

Year:

2020

Collaborators (5)

Juan Trujillo

IRELAND

View details

Michel Erlewyn-Lajeunesse

University of Southampton

UNITED KINGDOM

View details

Michael O'Sullivan

University of Western Australia

AUSTRALIA

View details

Aikaterini Anagnostou

Professor of Pediatrics & Allergy

Texas Children's Hospital

UNITED STATES

View details

Edwin Kim

Associate Professor

University of North Carolina

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Christopher Parrish

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

Efficacy and Safety of Epicutaneous Immunotherapy in Peanut-Allergic Toddlers: Open-Label Extension to EPITOPE.

Addressing health disparities in food allergy: A Position Statement of the AAAAI Prior Authorization Task Force

Introduction of allergenic foods after treatment with omalizumab.

Omalizumab for the Treatment of Multiple Food Allergies

Phase 3 Trial of Epicutaneous Immunotherapy in Toddlers with Peanut Allergy

Intravenous access is rarely necessary in food protein-induced enterocolitis syndrome oral food challenges

A review of food allergy panels and their consequences

A Case Series on the Use of Dupilumab for Treatment of Refractory Eosinophilic Gastrointestinal Disorders.

Reply to "Oral food challenge protocol for food protein-induced enterocolitis syndrome: time for a change?"

Conducting an Oral Food Challenge: An Update to the 2009 Adverse Reactions to Foods Committee Work Group Report.

Collaborators (5)

Juan Trujillo

Michel Erlewyn-Lajeunesse

Michael O'Sullivan

Aikaterini Anagnostou

Edwin Kim

Make your next move.